HARLOW, England & HYDERABAD, India--(BUSINESS WIRE)--Argenta Discovery Limited, the respiratory drug discovery and development company, and Dr. Reddy’s Laboratories (NYSE:RDY), today announce a major milestone in their development programme targeting a novel disease-modifying approach to treat the underlying cause of certain chronic respiratory diseases including chronic obstructive pulmonary disease (COPD) and severe asthma.
